Purple Biotech Ltd. (PPBT) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Purple Biotech Ltd.

    NASDAQ: PPBT · Real-Time Price · USD
    0.59
    0.02 (3.38%)
    At close: Oct 03, 2025, 3:59 PM
    0.60
    1.21%
    Pre-market: Oct 06, 2025, 07:44 AM EDT

    Purple Biotech Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -7.28M -19.88M -21.76M -17.83M
    Depreciation & Amortization
    		 186K 197K 201K 231K
    Stock-Based Compensation
    		 582K 1.88M 2.41M 2.08M
    Other Working Capital
    		 -2.26M -1.06M 11K 27K
    Other Non-Cash Items
    		 -3.52M -2.39M -843K -108K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -4.33M 274K 3.25M 550K
    Operating Cash Flow
    		 -14.37M -19.93M -16.73M -15.07M
    Capital Expenditures
    		 n/a -3K -228K -115K
    Cash Acquisitions
    		 n/a -3.55M n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 189K 16.68M 19.82M 13.16M
    Other Investing Acitivies
    		 320K 755K 324K 359K
    Investing Cash Flow
    		 509K 13.88M 19.91M 13.41M
    Debt Repayment
    		 -183K -168K -165K -153K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 1.15M 4.05M -219K 1.1M
    Financial Cash Flow
    		 6.77M 5.45M 1.11M 1.51M
    Net Cash Flow
    		 -7.09M -541K 4.14M -357K
    Free Cash Flow
    		 -14.37M -19.93M -16.96M -15.19M

    Add to Watchlist